Astrana Health, Inc.
Company Stats
- Market Cap
- $2.0B
- as of Sep 30, 2026
- Enterprise Value
- $2.6B
- Shares Outstanding
- 55.7M
- Free Float
- 52.8%
Income Statement
- Revenue
- $3.2B
- Operating Income
- $78.5M
- Net Income
- $22.5M
- EBITDA
- $124.3M
- Revenue Growth, 3Y
- 40.6%
- FCF Margin, 3Y Avg
- 2.8%
- FCF Margin, Worst Year
- 2.2%
Cash Flow
- Free Cash Flow
- $104.5M
- FCF Yield
- 5.3%
- Owner FCF Yield
- 3.3%
Balance Sheet
- Cash & Equivalents
- $429.5M
- Total Debt
- $1.1B
- Net Debt
- $622.8M
- Net Debt / EBITDA
- 5.01x
- EV / EBITDA
- 20.96x
- Net Debt / EBIT
- 7.93x
Returns & Capital
- Dividends Paid
- $7.9M
- Dividend Yield
- 0.4%
- Dividend Payout, 3Y Avg
- 48.9%
- Share Repurchases
- $25.6M
- Buyback Yield, 3Y Avg
- 0.6%
- SBC, 3Y Avg
- $31.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $3.2B | $104.5M | 3.3% |
| FY2024 | $2.0B | $44.2M | 2.2% |
| FY2023 | $1.4B | $39.7M | 2.9% |
| FY2022 | $1.1B | $59.2M | 5.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges